The DNA damage-signaling pathway has been implicated in the development of prostate cancer. Germline mutations in several genes (BRCA1, BRCA2, and CHEK2) whose
The DNA damage-signaling pathway has been implicated in the development of prostate cancer since germline mutations in several genes (BRCA1, BRCA2, and CHEK2) w